Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (1) : 16-20     DOI: 10.1007/s11684-010-0007-8
Research articles |
Prevalence of cardiovascular diseases in China
Jun-Jie XIAO MD,Yi-Han CHEN MD, PhD,
Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China;Key Laboratory of Arrhythmias of Ministry of Education, Tongji University, Shanghai 200065, China;Institute of Medical Genetics, Tongji University, Shanghai 200065, China;
Download: PDF(93 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Cardiovascular diseases (CVD) cause one third of all deaths in China, and the number is anticipated to double by 2020. They also greatly result in disability and adjusted life year loss. The prevalence of CVD has become a new burden for China, due to an aging population, smoking, and changes in dietary habits and lifestyles. As the largest developing country, China needs to tailor her own national policies for managing CVD with full consideration of epidemiology, local needs, and affordability. Smoking cessation, increased physical activity, control of hypertension and hypercholesterolemia, and maintenance of a “traditional Chinese” diet should be important strategies for reducing the burden of CVD in China. Health officials in China should take their responsibilities to implement educational and preventive measures seriously.
Keywords cardiovascular diseases      prevalence      China      risk factors      prevention      
Issue Date: 05 March 2010
URL:     OR
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X. Prevalence,awareness, treatment, and control of hypertension in China: data fromthe China national nutrition and health survey 2002. Circulation, 2008, 118(25): 2679–2686

doi: 10.1161/CIRCULATIONAHA.108.788166
Mark D B, Van de Werf F J, Simes R J, White H D, Wallentin L C, Califf R M, Armstrong P W; VIGOUR Group for the VG. Cardiovascular disease on a global scale: defining the path forwardfor research and practice. Eur Heart J, 2007, 28(21): 2678–2684

doi: 10.1093/eurheartj/ehm411
Klein W. Cardiovascular disease at the turn of the millennium:focus on Europe. Eur Heart J Suppl, 2001, 3(Supplement M): M2–M6

doi: 10.1016/S1520-765X(01)90075-6
Hua W, Zhang L F, Wu Y F, Liu X Q, Guo D S, Zhou H L, Gou Z P, Zhao L C, Niu H X, Chen K P, Mai J Z, Chu L N, Zhang S. Incidence of sudden cardiac death inChina: analysis of 4 regional populations. J Am Coll Cardiol, 2009, 54(12): 1110–1118

doi: 10.1016/j.jacc.2009.06.016
Yusuf S, Reddy S, Ounpuu S, Anand S. Globalburden of cardiovascular diseases: part I: general considerations,the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001, 104(22): 2746–2753

doi: 10.1161/hc4601.099487
He Y, Jiang B, Wang J, Feng K, Chang Q, Zhu S, Fan L, Li X, Hu F B. BMI versus the metabolic syndrome in relation to cardiovascularrisk in elderly Chinese individuals. DiabetesCare, 2007, 30(8): 2128–2134

doi: 10.2337/dc06-2402
He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen C S, Chen J, Wildman R P, Klag M J, Whelton P K. Major causes of death among men and women in China. N Engl J Med, 2005, 353(11): 1124–1134

doi: 10.1056/NEJMsa050467
Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton P K, He J. Factors associatedwith hypertension awareness, treatment, and control in a representativesample of the Chinese population. Hypertension, 2004, 43(3): 578–585

doi: 10.1161/01.HYP.0000116302.08484.14
Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase incoronary heart disease mortality in Beijing between 1984 and 1999. Circulation, 2004, 110(10): 1236–1244

doi: 10.1161/01.CIR.0000140668.91896.AE
Zhang X H, Lu Z L, Liu L. Coronary heart disease in China. Heart, 2008, 94(9): 1126–1131

doi: 10.1136/hrt.2007.132423
Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA project: a collaborativestudy on trends and determinants in cardiovascular diseases in China,Part I: morbidity and mortality monitoring. Circulation, 2001, 103(3): 462–468
Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser S H, Ehrlich J R. Changes in microRNA-1 expression and I(K1) up-regulation in humanatrial fibrillation. Heart Rhythm, 2009, 6(12): 1802–1809

doi: 10.1016/j.hrthm.2009.08.035
Coronel R, Langerveld J, Boersma L V, Wever E F, Bon L, van Dessel P F, Linnenbank A C, van Gilst W H, Ernst S M, Opthof T, van Hemel N M. Left atrial pressure reduction for mitral stenosis reverses leftatrial direction dependent conduction abnormalities. Cardiovasc Res, 2009,

doi: 10.1093/CVR/CVP374

doi: 10.1093/CVR/CVP374
Virtanen J K, Mursu J, Voutilainen S, Tuomainen T P. Serum long-chain n-3 polyunsaturated fatty acids andrisk of hospital diagnosis of atrial fibrillation in men. Circulation, 2009, 120(23): 2315–2321

doi: 10.1161/CIRCULATIONAHA.109.852657
Hu D, Sun Y. Epidemiology,risk factors for stroke, and management of atrial fibrillation inChina. J Am Coll Cardiol, 2008, 52(10): 865–868

doi: 10.1016/j.jacc.2008.05.042
Zhou Z, Hu D. An epidemiologicalstudy on the prevalence of atrial fibrillation in the Chinese populationof mainland China. J Epidemiol, 2008, 18(5): 209–216

doi: 10.2188/jea.JE2008021
He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton P K. Serum total and lipoproteincholesterol levels and awareness, treatment, and control of hypercholesterolemiain China. Circulation, 2004, 110(4): 405–411

doi: 10.1161/01.CIR.0000136583.52681.0D
Zhang S. Atrial fibrillation in mainland China: epidemiology andcurrent management. Heart, 2009, 95(13): 1052–1055

doi: 10.1136/hrt.2008.146589
Pascual-Figal D A, Ordonez-Llanos J, Tornel P L, Vazquez R, Puig T, Valdes M, Cinca J, de Luna A B, Bayes-Genis A. Soluble ST2 for predicting sudden cardiac death in patientswith chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol, 2009, 54(23): 2174–2179

doi: 10.1016/j.jacc.2009.07.041
George A L Jr. Common genetic variants in sudden cardiac death. Heart Rhythm, 2009, 6(11 Suppl): S3–9

doi: 10.1016/j.hrthm.2009.08.024
Colquhoun S M, Carapetis J R, Kado J H, Steer A C. Rheumatic heart disease and its control in the Pacific. Expert Rev cardiovas Ther, 2009, 7(12): 1517–1524

doi: 10.1586/erc.09.145
Zhimin W, Yubao Z, Lei S, Xianliang Z, Wei Z, Li S, Hao W, Jianjun L, Detrano R, Rutai H. Prevalence of chronic rheumaticheart disease in Chinese adults. Int JCardiol, 2006, 107(3): 356–359

doi: 10.1016/j.ijcard.2005.03.048
Knirsch W, Zingg W, Bernet V, Balmer C, Dimitropoulos A, Pretre R, Bauersfeld U, Latal B. Determinants of body weightgain and association with neurodevelopmental outcome in infants operatedfor congenital heart disease. InteractCardiovasc Thorac Surg, 2009,

doi: 10.1510/icvts.2009.216135

doi: 10.1510/icvts.2009.216135
Yang X Y, Li X F, Lu X D, Liu Y L. Incidence of congenital heart disease in Beijing, China. Chin Med J (Engl), 2009, 122(10): 1128–1132
Callow A D. Cardiovascular disease 2005-the global picture. Vascul Pharmacol, 2006, 45(5): 302–307

doi: 10.1016/j.vph.2006.08.010
Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds R F, Su S, Whelton P K, He J. Prevalence, awareness, treatment,and control of hypertension in china. Hypertension, 2002, 40(6): 920–927

doi: 10.1161/01.HYP.0000040263.94619.D5
Yusuf S, Reddy S, Ounpuu S, Anand S. Globalburden of cardiovascular diseases: Part II: variations in cardiovasculardisease by specific ethnic groups and geographic regions and preventionstrategies. Circulation, 2001, 104(23): 2855–2864

doi: 10.1161/hc4701.099488
Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds R F, Whelton P K, He J. Prevalence of cardiovascular disease risk factor clusteringamong the adult population of China: results from the InternationalCollaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation, 2005, 112(5): 658–665

doi: 10.1161/CIRCULATIONAHA.104.515072
Liu L. Cardiovascular diseases in China. Biochem Cell Biol, 2007, 85(2): 157–163

doi: 10.1139/O07-004
Cheng T O. The current state of cardiology in China. Int J Cardiol, 2004, 96(3): 425–439

doi: 10.1016/j.ijcard.2003.10.011
Howard B V, Comuzzie A, Devereux R B, Ebbesson S O, Fabsitz R R, Howard W J, Laston S, Maccluer J W, Silverman A, Umans J G, Wang H, Weissman N J, Wenger C R. Cardiovascular disease prevalence and its relation torisk factors in Alaska Eskimos. Nutr MetabCardiovasc Dis, 2009,

doi: 10.1016/j

doi: 10.1016/j
Liu M, Wu B, Wang W Z, Lee L M, Zhang S H, Kong L Z. Stroke in China: epidemiology, prevention, and managementstrategies. Lancet Neurol, 2007, 6(5): 456–464

doi: 10.1016/S1474-4422(07)70004-2
Berger J S, Bhatt D L, Steinhubl S R, Shao M, Steg P G, Montalescot G, Hacke W, Fox K A, Lincoff A M, Topol E J, Berger P B. Smoking, clopidogrel, and mortality in patients with establishedcardiovascular disease. Circulation, 2009, 120(23): 2337–2344

doi: 10.1161/CIRCULATIONAHA.109.866533
Hu J, Wallace D C, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetesliving in Beijing, China. Public HealthNurs, 2009, 26(6): 500–511

doi: 10.1111/j.1525-1446.2009.00810.x
Cheng T O. Smoking and diabetes in Chinese men. Postgrad Med J, 2001, 77(910): 551

doi: 10.1136/pmj.77.910.551a
Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds R F, Whelton P K, He J. Cigarette smoking and exposureto environmental tobacco smoke in China: the international collaborativestudy of cardiovascular disease in Asia. Am J Public Health, 2004, 94(11): 1972–1976

doi: 10.2105/AJPH.94.11.1972
McGuire K A, Janssen I, Ross R. Ability of physical activityto predict cardiovascular disease beyond commonly evaluated cardiometabolicrisk factors. Am J Cardiol, 2009, 104(11): 1522–1526

doi: 10.1016/j.amjcard.2009.07.023
Fu F H, Fung L. The cardiovascularhealth of residents in selected metropolitan cities in China. Prev Med, 2004, 38(4): 458–467

doi: 10.1016/j.ypmed.2003.11.022
Kelly T N, Gu D, Chen J, Huang J F, Chen J C, Duan X, Wu X, Yau C L, Whelton P K, He J. Hypertension subtype andrisk of cardiovascular disease in Chinese adults. Circulation, 2008, 118(15): 1558–1566

doi: 10.1161/CIRCULATIONAHA.107.723593
Lee D E, Cooper R S. Recommendations for global hypertension monitoring and prevention. Curr Hypertens Rep, 2009, 11(6): 444–449

doi: 10.1007/s11906-009-0075-9
Tang J L, Hu Y H. Drugs forpreventing cardiovascular disease in China. BMJ, 2005, 330(7492): 610–611

doi: 10.1136/bmj.330.7492.610
[1] Huiqin Zhong,Ya Shao,Ling Fan,Tangshen Zhong,Lu Ren,Yan Wang. Perceived resource support for chronic illnesses among diabetics in north-western China[J]. Front. Med., 2016, 10(2): 219-227.
[2] Alexandra Urman,H. Dean Hosgood. Curbing the burden of lung cancer[J]. Front. Med., 2016, 10(2): 228-232.
[3] Chunsong Hu,Qinghua Wu. Health: a dream from reality to the future[J]. Front. Med., 2016, 10(2): 233-235.
[4] Yi Cao. Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications[J]. Front. Med., 2015, 9(3): 261-274.
[5] Xijin Xu,Xiang Zeng,H. Marike Boezen,Xia Huo. E-waste environmental contamination and harm to public health in China[J]. Front. Med., 2015, 9(2): 220-228.
[6] Xinjian Li,Minna Cheng,Hao Zhang,Ting Ke,Yisheng Chen. Prevalence and determinations of physical inactivity among public hospital employees in Shanghai, China: a cross-sectional study[J]. Front. Med., 2015, 9(1): 100-107.
[7] James S. Park,Calvin Pan. Current recommendations of managing HBV infection in preconception or pregnancy[J]. Front. Med., 2014, 8(2): 158-165.
[8] Rui Yu,Rong Fan,Jinlin Hou. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China[J]. Front. Med., 2014, 8(2): 135-144.
[9] Lizhe Ai, Yaqin Yu, Xiaoli Liu, Chong Wang, Jieping Shi, Hui Sun, Qiong Yu. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?[J]. Front Med, 2014, 8(1): 113-117.
[10] Xiangwei Li, Yu Yang, Jianmin Liu, Feng Zhou, Wei Cui, Ling Guan, Fei Shen, Cong Gao, Mufei Li, Qi Jin, Lei Gao. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis[J]. Front Med, 2013, 7(3): 354-366.
[11] Zhiming Zhu, Peijian Wang, Shuangtao Ma. Metabolic hypertension: concept and practice[J]. Front Med, 2013, 7(2): 201-206.
[12] Hussein Naji, Rajaa Mustafa. Circumcision of preschool boys in Baghdad, Iraq: prevalence, current practice and complications[J]. Front Med, 2013, 7(1): 122-125.
[13] Wei Li, Shan Lu, Zhigang Cui, Jinghua Cui, Haijian Zhou, Yiqing Wang, Zhujun Shao, Changyun Ye, Biao Kan, Jianguo Xu. PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China[J]. Front Med, 2012, 6(4): 366-375.
[14] Jin Gao, Ben Panizza, Newell W. Johnson, Scott Coman, Alan R. Clough. Basic consideration of research strategies for head and neck cancer[J]. Front Med, 2012, 6(4): 339-353.
[15] Xinjian Li, Jiying Xu, Haihong Yao, Yanfei Guo, Minna Chen, Wei Lu. Obesity and overweight prevalence and its association with undiagnosed hypertension in Shanghai population, China: a cross-sectional population-based survey[J]. Front Med, 2012, 6(3): 322-328.
Full text